SI
DXCM icon

Sava Infond’s DexCom DXCM Stock Holding History

Sava Infond’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482K Sell
7,155
-995
-12% -$66.3K 0.03% 146
2026
Q1 		$512K Sell
8,150
-1,400
-15% -$97.5K 0.07% 135
2025
Q4 		$634K Buy
9,550
+2,100
+28% +$136K 0.09% 122
2025
Q3 		$501K Buy
7,450
+1,350
+22% +$107K 0.07% 123
2025
Q2 		$532K Hold
6,100
– – 0.08% 122
2025
Q1 		$417K Hold
6,100
– – 0.08% 127
2024
Q4 		$474K Buy
+6,100
New +$452K 0.08% 120

Other funds holding DXCM

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return

Sava Infond's DXCM Position: Q2 2026 in Review

Sava Infond reduced its DexCom (DXCM) stake by 12% in Q2 2026, selling an estimated $66.3K and leaving 7,155 shares worth $482K. The position accounts for 0.03% of the portfolio, ranked #146.

Sava Infond first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $634K in Q4 2025. 163 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Sava Infond held 7,155 shares of DexCom worth $482K as of Q2 2026.
  • Sava Infond sold 995 DexCom shares in Q2 2026, an estimated $66.3K.
  • DexCom made up 0.03% of Sava Infond's portfolio in Q2 2026, its #146 holding.
  • Sava Infond first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • Sava Infond's DexCom position peaked at $634K in Q4 2025.
  • 163 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.